✦ LIBER ✦

Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo

✍ Scribed by Lloyd D. Fisher; Michael Gent; Harry R. Büller

Book ID: 117842315
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 119 KB
Volume: 141
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2001.111262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Active control trials: what about a plac

Active control trials: what about a placebo? A method illustrated with clopidogrel, aspirin and placebo

✍ L.D. Fisher 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 158 KB

249 LUMIRACOXIB IMPROVES PAIN AND FUNCTI

249 LUMIRACOXIB IMPROVES PAIN AND FUNCTIONAL STATUS IN PATIENTS WITH PRIMARY HIP OSTEOARTHRITIS: A 13-WEEK, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, ACTIVE COMPARATOR TRIAL

✍ T.J. Schnitzer; I.D. Dattani; B. Seriolo; H. Schneider; S. Yu; L. Tseng; R. Rebu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Comparison of two dosing methods for ind

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial

✍ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in

Efficacy and tolerability of MK-0974 (te

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

✍ Tony W Ho; Michel D Ferrari; David W Dodick; Vince Galet; James Kost; Xiaoyin Fa 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 177 KB

Effects of aspirin plus extended-release

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

✍ Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ôunp 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB